Send the following on WhatsApp
Continue to ChatCybin Completes Dosing in Phase 2 Study of CYB003 for the Treatment of Major Depressive Disorder https://www.nxtpsychedelics.com/news/articles/psychedelics/cybin-completes-dosing-in-phase-2-study-of-cyb003-for-the-treatment-of-major-depressive-disorder/